Treating MAP using specific antibiotics that MAP may be susceptible to has been examined and the results are unclear but tentatively beneficial.Crohns is common in parts of the world where helminthic colonisation is rare and uncommon in those areas where most people carry worms. Infections with helminths may alter the autoimmune response that causes the disease. Trials of extracts from the worm Trichuris suis showed promising results when used in people with IBD. However, these trials (TRUST -I & TRUST -II) failed in Phase 2 clinical trials and were then discontinued after consistent failure in both North America and Europe.There is no good evidence that thalidomide or lenalidomide is useful to bring about or maintain remission. References
Further reading
Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE (April 2018). "ACG Clinical Guideline: Management of Crohns Disease in Adults". Am. J. Gastroenterol. 113 (4): 481–517. doi:10.1038/ajg.2018.27. PMID 29610508. External links
"Crohns disease". MedlinePlus. U.S. National Library of Medicine.
Hydrocodone/aspirin (INNs) is an oral combination drug formulation of the opioid analgesic hydrocodone and the nonsteroidal anti-inflammatory drug (NSAID) aspirin that is used in the treatment of chronic and acute pain. It is sold under brand names including Alor 5/500, Azdone, Damason-P, Lortab ASA, and Panasal 5/500. Adverse effects
See also
Hydrocodone/paracetamol
Hydrocodone/ibuprofen
Oxycodone/aspirin


== References ==